Key Highlights: Implications: Alkem’s launch of NeuCeno (cenobamate) introduces India’s first cenobamate-based anti‑seizure medication for adults with partial‑onset seizures, adding a high...
Summary: The Top 10 Indian Pharmaceutical Companies of 2026 demonstrate the continued strength and global competitiveness of India’s pharmaceutical sector, led by Sun Pharmaceutical Industries, ...
Key Highlights: Implications: By pricing its once‑weekly semaglutide at around ₹450 per week via a pre‑filled disposable pen, Alkem is positioning one of the lowest‑cost GLP‑1 op...
